Study of Ayurvedic decoction (Madanphaladi kwath) in participants of Obesity (Sthaulya) associated with raised serum cholesterol levels.
- Conditions
- Health Condition 1: E660- Obesity due to excess caloriesHealth Condition 2: E780- Pure hypercholesterolemia
- Registration Number
- CTRI/2023/11/059645
- Lead Sponsor
- Dr Prajakta Subhash Bodkhe
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Subjects between age group 20-30 years irrespective of gender, religion, socioeconomic
strata will be selected.
2. Subjects having signs and symptoms of Sthaulya (Medorog) that is Atikshudha, Atipipasa,
Swedadhikya, Nidradhikya, Daurbalya, Sweda durgandhya etc. [13]
3. Subjects having BMI between 25-34.9 with raised serum cholesterol range between 200-
239 mg/dl on laboratory investigations.
1. Subjects having severe hypertension, endocrine disorders, Cushing’s Syndrome, any major
disease or other associated complications.
2. Pregnant or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO STUDY OF APATARPAN CHIKITSA SIDDHANTA WITH SPECIAL REFERENCE TO <br/ ><br>EFFICACY OF MADANPHALADI KWATH IN STHAULYA ASSOCIATED WITH <br/ ><br>HYPERCHOLESTEROLEMIATimepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method 1. The effect of drug will be assessed on the basis of the subjective as well as objective parameters. <br/ ><br> <br/ ><br> 2. The Subjective parameters will be based on signs and symptoms of Sthaulya compiled from classical references and difference will be assessed by the Gradation method. <br/ ><br>Percentage of relief in Symptoms will be calculated according to the difference <br/ ><br>between pre-treatment total symptoms score and post treatment total symptoms score. <br/ ><br> <br/ ><br>3.Serum Cholesterol, Serum HDL, Serum LDL, Serum Triglyceride and BMI will be carried out <br/ ><br>before and after study (on Day 0 and Day 90).Timepoint: 6-7 Months.